OPKO Health Inc (OPK)
1.28
+0.02
(+1.59%)
USD |
NASDAQ |
May 10, 16:00
1.28
0.00 (0.00%)
After-Hours: 19:03
OPKO Health Enterprise Value: 1.153B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.153B |
| May 08, 2024 | 1.146B |
| May 07, 2024 | 1.181B |
| May 06, 2024 | 1.195B |
| May 03, 2024 | 1.181B |
| May 02, 2024 | 1.181B |
| May 01, 2024 | 1.160B |
| April 30, 2024 | 1.125B |
| April 29, 2024 | 1.139B |
| April 26, 2024 | 1.153B |
| April 25, 2024 | 1.125B |
| April 24, 2024 | 1.132B |
| April 23, 2024 | 1.146B |
| April 22, 2024 | 1.132B |
| April 19, 2024 | 1.132B |
| April 18, 2024 | 1.132B |
| April 17, 2024 | 1.146B |
| April 16, 2024 | 1.118B |
| April 15, 2024 | 1.132B |
| April 12, 2024 | 1.132B |
| April 11, 2024 | 1.170B |
| April 10, 2024 | 1.160B |
| April 09, 2024 | 1.236B |
| April 08, 2024 | 1.250B |
| April 05, 2024 | 1.215B |
| Date | Value |
|---|---|
| April 04, 2024 | 1.222B |
| April 03, 2024 | 1.215B |
| April 02, 2024 | 1.215B |
| April 01, 2024 | 1.188B |
| March 31, 2024 | 1.111B |
| March 28, 2024 | 989.84M |
| March 27, 2024 | 899.23M |
| March 26, 2024 | 857.41M |
| March 25, 2024 | 857.41M |
| March 22, 2024 | 825.76M |
| March 21, 2024 | 801.65M |
| March 20, 2024 | 773.77M |
| March 19, 2024 | 760.04M |
| March 18, 2024 | 756.69M |
| March 15, 2024 | 777.11M |
| March 14, 2024 | 770.56M |
| March 13, 2024 | 794.19M |
| March 12, 2024 | 800.18M |
| March 11, 2024 | 809.94M |
| March 08, 2024 | 820.82M |
| March 07, 2024 | 816.49M |
| March 06, 2024 | 807.92M |
| March 05, 2024 | 805.06M |
| March 04, 2024 | 850.44M |
| March 01, 2024 | 845.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
756.69M
Minimum
Mar 18 2024
4.254B
Maximum
Jul 21 2020
1.926B
Average
1.599B
Median
Enterprise Value Benchmarks
| Innerscope Hearing Technologies Inc | -- |
| Stryker Corp | 136.50B |
| Perspective Therapeutics Inc | 1.049B |
| Xtant Medical Holdings Inc | 121.55M |
| Asensus Surgical Inc | 50.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -81.84M |
| Revenue (Quarterly) | 173.69M |
| Total Expenses (Quarterly) | 245.16M |
| EPS Diluted (Quarterly) | -0.12 |
| Gross Profit Margin (Quarterly) | 24.22% |
| Profit Margin (Quarterly) | -47.12% |
| Earnings Yield | -27.34% |
| Normalized Earnings Yield | -24.62 |